161 related articles for article (PubMed ID: 22423979)
21. A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.
Parija S; Kumar A
Int J Bioinform Res Appl; 2011; 7(1):1-14. PubMed ID: 21441093
[TBL] [Abstract][Full Text] [Related]
22. Regulation of BRCA1 expression and its relationship to sporadic breast cancer.
Mueller CR; Roskelley CD
Breast Cancer Res; 2003; 5(1):45-52. PubMed ID: 12559046
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
24. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
25. [BRCA1 and BRCA2 - pathologists starting kit].
Škapa P
Cesk Patol; 2016; 52(4):193-196. PubMed ID: 27869444
[TBL] [Abstract][Full Text] [Related]
26. BRCA1: Beyond double-strand break repair.
Alli E; Ford JM
DNA Repair (Amst); 2015 Aug; 32():165-171. PubMed ID: 25956865
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.
Khoo US; Ozcelik H; Cheung AN; Chow LW; Ngan HY; Done SJ; Liang AC; Chan VW; Au GK; Ng WF; Poon CS; Leung YF; Loong F; Ip P; Chan GS; Andrulis IL; Lu J; Ho FC
Oncogene; 1999 Aug; 18(32):4643-6. PubMed ID: 10467410
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
29. BRCA1 suppresses osteopontin-mediated breast cancer.
El-Tanani MK; Campbell FC; Crowe P; Erwin P; Harkin DP; Pharoah P; Ponder B; Rudland PS
J Biol Chem; 2006 Sep; 281(36):26587-601. PubMed ID: 16807234
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the BRCA1 Tumor Suppressor Network.
Jiang Q; Greenberg RA
J Biol Chem; 2015 Jul; 290(29):17724-17732. PubMed ID: 26048987
[TBL] [Abstract][Full Text] [Related]
31. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
Maxwell KN; Wubbenhorst B; Wenz BM; De Sloover D; Pluta J; Emery L; Barrett A; Kraya AA; Anastopoulos IN; Yu S; Jiang Y; Chen H; Zhang NR; Hackman N; D'Andrea K; Daber R; Morrissette JJD; Mitra N; Feldman M; Domchek SM; Nathanson KL
Nat Commun; 2017 Aug; 8(1):319. PubMed ID: 28831036
[TBL] [Abstract][Full Text] [Related]
32. BRCA1: the enigma of tissue-specific tumor development.
Monteiro AN
Trends Genet; 2003 Jun; 19(6):312-5. PubMed ID: 12801723
[TBL] [Abstract][Full Text] [Related]
33. Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.
Bielinska B; Gaj P; Kluska A; Nowakowska D; Balabas A; Dabrowska M; Niwinska A; Gruchota J; Zub R; Skasko E; Steffen J; Ostrowski J; Siedlecki JA
Fam Cancer; 2013 Dec; 12(4):691-8. PubMed ID: 23657760
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.
Jacot W; Thezenas S; Senal R; Viglianti C; Laberenne AC; Lopez-Crapez E; Bibeau F; Bleuse JP; Romieu G; Lamy PJ
BMC Cancer; 2013 Nov; 13():523. PubMed ID: 24191908
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis.
Pongsavee M; Patmasiriwat P; Saunders GF
Int J Mol Sci; 2009 Sep; 10(9):4187-4197. PubMed ID: 19865540
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic changes in BRCA1-mutated familial breast cancer.
Downs B; Wang SM
Cancer Genet; 2015 May; 208(5):237-40. PubMed ID: 25800897
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 gene: function and deficiency.
Takaoka M; Miki Y
Int J Clin Oncol; 2018 Feb; 23(1):36-44. PubMed ID: 28884397
[TBL] [Abstract][Full Text] [Related]
38. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
[TBL] [Abstract][Full Text] [Related]
39. Understanding the functions of BRCA1 in the DNA-damage response.
Yun MH; Hiom K
Biochem Soc Trans; 2009 Jun; 37(Pt 3):597-604. PubMed ID: 19442256
[TBL] [Abstract][Full Text] [Related]
40. BAP1, a candidate tumor suppressor protein that interacts with BRCA1.
Jensen DE; Rauscher FJ
Ann N Y Acad Sci; 1999; 886():191-4. PubMed ID: 10667217
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
